PARP1 and cancer: According to Hottiger et al., cytoplasmic ADP-ribosylation levels and patient prognosis vary according to the type of cancer, indicating a differential expression of ARTs in the cytoplasm, consistent with the findings of several recent studies concerning the PARP family and cancer.